The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Tau filaments in neurodegenerative diseases
Open accessAbstract
The ordered assembly of Tau protein into abnormal filamentous inclusions is a defining characteristic of many human neurodegenerative diseases. Thirty years ago, we reported that Tau is an integral component of the intraneuronal filaments of Alzheimer's disease. All six brain Tau isoforms make up those filaments. Twenty years ago, we and others showed that mutations in MAPT, the Tau gene, cause familial forms of frontotemporal dementia, thus proving that dysfunction of Tau protein is sufficient to cause neurodegeneration and dementia. More recently, we showed that high‐resolution structures of Tau filaments from human brain can be determined by electron cryo‐microscopy. These filaments may form the seeds that underlie the prion‐like properties of aggregated tau.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In AD, tau becomes truncated and hyperphosphorylated (3), which can increase the risk for tau to aggregate into the paired helical filaments (PHF) that are found in neurofibrillary tangles (NFT) and neuropil treads in the brains of patients with AD (1).”
From Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease (2020) · cites this paper as [1]
In the citing paper
“Accumulation of Aβ fibrils is thought to be an initiating factor in AD and necessary for the formation of tau aggregates (1).”
From Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease (2020) · cites this paper as [1]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationCryo-EM structures of tau filaments from Alzheimer’s disease
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061
Self-citationMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Self-citationTau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citationGoedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citationTau protein liquid–liquid phase separation can initiate tau aggregation
Wegmann, S., Eftekharzadeh, B., Tepper, K., Zoltowska, K. M., Bennett, R. E., Dujardin, S., Laskowski, P. R., MacKenzie, D., Kamath, T., Commins, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798049 · Cited by 1,102
Cited by
Sorted by citations
Items 101–127 of 127
Hovhannisyan, Y., Yeritsyan, H., Hakobjanyan, G., Petrosyan, G., Harutyunyan, H. A., Muradyan, A. A., Azizian, A., & Yenkoyan, K. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146965 · Cited by 4
Metformin, Microbiota and Health
Paz, G. S., & Fernandes, J. (2022) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00032 · Cited by 3
Atkinson, P. J., Swami, M., Ridgway, N., Roberts, M., Kinghorn, J., Warner, T. T., Staddon, J. M., & Takle, A. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103732 · Cited by 3
A Review on the Correlation between the Pathology of Alzheimer's Disease and microRNA
Kim, S.-J., & Cho, H. (2021) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2021.27.4.208 · Cited by 2
He, X., Man, V. H., Gao, J., & Wang, J. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01448 · Cited by 2
PET Imaging of a Transgenic Tau Rat Model SHR24 with [18F]AV1451
Ramakrishnan, N. K., Zhao, A. Z., Thompson, S., Sephton, S. M., Williamson, D. J., Smolek, T., Žilka, N., & Aigbirhio, F. I. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01972-4 · Cited by 2
Recently Progressed Postbiotics as Nutraceuticals
Jeong, G. (2021) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2021.1.e33 · Cited by 2
Hromádková, L., Kim, C., Haldiman, T., Siddiqi, M. K., Surewicz, K. A., Urquhart, K., Sadruddin, D.-E.-N., Peng, L., Zhu, X., Surewicz, W. K., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012926 · Cited by 2
Loo, W. X. W., Sio, J. S., Yap, K., Loo, Y. S., Lim, H. X., Zhang, S., Liu, H., & Ng, C. S. (2026) · Aggregate · doi:10.1002/agt2.70280 · Cited by 1
Arsiccio, A., Liu, X., Ganguly, P., Buratto, S. K., Bowers, M. T., & Shea, J. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00433 · Cited by 1
Liu, Q.-Q., Ding, S.-K., & Shang, Y. Z. (2020) · International Journal of Medicinal Plants and Natural Products · doi:10.20431/2454-7999.0604001 · Cited by 1
Nadel, C. M., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., & Gestwicki, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553575 · Cited by 1
Tau proteolysis mechanisms and relevance for tauopathies
Quinn, J. P. (2019) · Research Explorer (The University of Manchester)
Yamamoto, T., Okamura, Y., Tsukui, R., Kato, Y., Onizuka, H., & Masui, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108063
Potential Therapeutic Strategies for Muscular Dystrophy
Gaina, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102255
Evidenced-based biological prevention and intervention strategies of dementia: a narrative review
Abukuri, D. N. (2023) · Current Psychology · doi:10.1007/s12144-023-05017-x
Analysis of genes associated with Alzheimer's disease and endoplasmic reticulum stressPreprint
Liu, Z., & Li, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4334229/v1
Neurological Impact of Type I Interferon Dysregulation
Mylonas, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006023
Oakley, S. S., Marshall, K. E., Meisl, G., Copsey, A. C., Maina, M. B., Milton, R., Vorley, T., Storey, J. M. D., Harrington, C. R., Wischik, C. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.05.636249
Novel prostaglandin and isoprostane panel for evaluating Wilson’s Disease
Polat, M. Ç. A. Ü. L. T. İ. Ç. G., Durukan, B. M., İsrafilov, S., Çakmaklı, G. Y., İdilman, İ. S., Dağ, O., Karçaaltıncaba, M., Sökmensüer, C., Elibol, B., Balaban, Y. H., et al. (2025) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0330
Scotton, W. J., Valentino, R. R., Martínez-Carrasco, A., Real, R., Macpherson, H. L., Tamvaka, N., Mok, K. Y., Heckman, M. G., Kobylecki, C., Escott‐Price, V., et al. (2025) · medRxiv · doi:10.64898/2025.12.21.25342758
Evaluating the Impact of Phosphorylation on the Dynamics of the Tau Protein Proline-Rich Region
Stöckelmaier, J., Polato, G., Hritz, J., & Oostenbrink, C. (2026) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5c02011
Franck, M., Biswas, A., Jiang, P., Fernández-Campo, M., Mohapatra, S., Sankar, R., Dominguez‐Baquero, A., Ravatt, L. M., Nagy-Herczeg, B. K., Kantar, O. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.18.711671
Terras, F. (2020) · doi:10.70675/872df6d1ze1b9z4a8dzb02dzad4656ff10f0
Borcuk, C. (2021) · theses.fr (ABES) · doi:10.70675/c316f2dcz54d3z41cfzb3f5z99c7b2d3cd95 · Cited by 1
Rôle physiologique et pathologique de la kinésine Kif21b au cours de la migration neuronale
Alvarez, J. R. (2022) · theses.fr (ABES) · doi:10.70675/7fc29459z67a7z4bedzacbczf5ca6affb824
Sharma, S., & Singh, M. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202625201006
Metadata
- Authors
- Goedert, M.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Goedert, Michel
- ORCID
- Goedert, Michel
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2018-07
- Volume
- 592
- Issue
- 14
- Pages
- 2383-2391
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2803767896
- Cited by
- 127
- References
- 66
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 9 · 2023: 22 · 2022: 22 · 2021: 21 · 2020: 19 · 2019: 13 · 2018: 3
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- tau protein, tau filaments, neurodegenerative diseases, Alzheimer's disease, frontotemporal dementia, MAPT mutations, tau isoforms, protein aggregation, prion-like seeding
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, tau Proteins, Neurodegenerative Diseases, Protein Isoforms, Protein Aggregation, Pathological, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review